Showing 1,001 - 1,020 results of 227,685 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( a ((mean decrease) OR (a decrease)) ))', query time: 2.11s Refine Results
  1. 1001

    Differentially regulated genes in cells with increased or decreased expression of miR-106a-5p. by Feng Zhi (294362)

    Published 2013
    “…(C) A Venn diagram of the overlap of altered genes with increased or decreased miR-106a-5p expression. …”
  2. 1002
  3. 1003

    The major role of <i>sarA</i> in limiting <i>Staphylococcus aureus</i> extracellular protease production <i>in vitro</i> is correlated with decreased virulence in diverse clinical isolates in osteomyelitis by Mara J. Campbell (14579826)

    Published 2023
    “…We also showed that mutation of <i>sarA</i> results in a greater increase in protease production, and decrease in biofilm formation, than mutation of the loci encoding any of these other proteins. …”
  4. 1004
  5. 1005
  6. 1006
  7. 1007

    Supplementary Material for: Macrolide Therapy Decreases Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis by Yao G.-Y. (4139125)

    Published 2013
    “…Treatment might provide a significant benefit but only when therapy lasts more than 6 months.…”
  8. 1008
  9. 1009
  10. 1010
  11. 1011

    Fig 2A–2C and 2G–2L Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    “…We observed a marked decrease in nocturnal locomotion of <i>Opn5</i><sup><i>cre</i></sup><i>; Gnas</i><sup><i>fl/fl</i></sup> mice at both 28°C and 22°C, but no overall differences in energy expenditure, respiratory exchange, or food and water consumption. …”
  12. 1012
  13. 1013
  14. 1014
  15. 1015
  16. 1016
  17. 1017

    Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

    Published 2012
    “…<p><i>(A)</i> A single administration of CXCR3 antagonist (NBI-74330, 1 µM, 100 µL) induces a transient decrease in intraocular pressure (n = 10 in each group). …”
  18. 1018
  19. 1019
  20. 1020

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<b><i>Results:</i></b> Mean ± SE serum K decreased (maximum change per corresponding day, 0.6 ± 0.2 mEq/l, p = 0.009) and fecal K increased 58% on patiromer compared with the pretreatment week. …”